Branded Generics Market Publication Month: Â Aug 2019 | No. of Pages: 150| Report Code: TIPRE00005554 Â | Category: Pharmaceuticals Branded Generics Market to 2027 - Global Analysis and Forecasts by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics And Anti-Inflammatory); Distribution Channel (Hospitals pharmacies, Retail pharmacies. Online pharmacies, Drug stores); Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptic, Others); Formulation Type (Oral, Parental, Topical, Others)
E-Mail : sales@theinsightpartners.com
Branded Generics Market Publication Month: Â Aug 2019 | No. of Pages: 150| Report Code: TIPRE00005554 Â | Category: Pharmaceuticals
Introduction: Branded Generics are a patented drug, a novel dosage form of a generic drug with a definite trade name. The manufactures opt for this to gain profit from their customers who realize their medication has come off patent and that there are cheaper generics available. Â The Branded Generics market is anticipated to grow in the forecast, owing to the factors such as increasing off patent pharmaceutical companies, entry of new market players, changing medicine practices and rising awareness of the patients. The report aims to provide an overview of Branded Generics market with detailed market segmentation by therapeutic application, distribution channel, drug class, formulation type and geography. The global Branded Generics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Branded Generics market players and offers key trends and opportunities in the market.
E-Mail : sales@theinsightpartners.com
Branded Generics Market Publication Month: Â Aug 2019 | No. of Pages: 150| Report Code: TIPRE00005554 Â | Category: Pharmaceuticals
The global Branded Generics market is segmented on the basis of therapeutic application, distribution channel, drug class and formulation type. Based on therapeutic application the market is segmented into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory. Based on distribution channel the market is segmented into Hospitals pharmacies, Retail pharmacies. Online pharmacies, Drug stores. Based on drug class the market is segmented into Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptic, Others. Based on Formulation type the market is segmented into Oral, Parental, Topical, Others. The overall Branded Generics market size has been derived using both primary and secondary source. The research process begins with an exhaustive secondary research using internal and external sources to obtain qualitative and quantitative information related to the Branded Generics market. It also provides the overview and forecast for the global Branded Generics market based on all the segmentation provided with respect to five major reasons such as North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. Also, the primary interview was conducted with industry participants and commentators in order to validate data and analysis. The participants who typically take part in such a process include industry expert such as VPs, business development managers, market intelligence managers and national sales managers, and external consultant such as valuation experts, research analysts and key opinion leaders specializing in the Branded Generics industry.
E-Mail : sales@theinsightpartners.com
Branded Generics Market Publication Month: Aug 2019 | No. of Pages: 150| Report Code: TIPRE00005554 | Category: Pharmaceuticals
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Branded Generics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Branded Generics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region. The reports cover key developments in the Branded Generics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Branded Generics market are anticipated to lucrative growth opportunities in the future with the rising demand for Branded Generics market in the global market. Below mentioned is the list of few companies engaged in the Branded Generics market. Get a PDF Sample copy of Branded Generics Market: https://www.theinsightpartners.com/sample/TIPRE00005554
E-Mail : sales@theinsightpartners.com
Branded Generics Market Publication Month: Aug 2019 | No. of Pages: 150| Report Code: TIPRE00005554 | Category: Pharmaceuticals
The List of Companies
-
Mylan N.V Teva Pharmaceutical Industries Ltd GlaxoSmithKline plc Bausch Health (Valeant Pharmaceuticals) Sandoz International GmbH Zydus Cadila Par Pharmaceutical Lupin Pharmaceuticals, Inc Sanofi AstraZeneca Dr. Reddy's Laboratories Ltd Inquire more @ https://www.theinsightpartners.com/inquiry/TIPRE00005554
E-Mail : sales@theinsightpartners.com